Țară: Noua Zeelandă
Limbă: engleză
Sursă: Medsafe (Medicines Safety Authority)
Diclofenac sodium 25mg; ;
Novartis New Zealand Ltd
Diclofenac sodium 25 mg
25 mg
Enteric coated tablet
Active: Diclofenac sodium 25mg Excipient: Ammonia solution Colloidal silicon dioxide Hypromellose Silicone antifoam emulsion (Enteric-coat) Pigment Suspension White Pigment Suspension White (Colour-coat) Lactose monohydrate Macrogol 8000 Magnesium stearate Maize starch Methacrylic acid copolymer Microcrystalline cellulose Polyethylene glycol hydrogenated castor oil Povidone Purified talc Purified water Sodium starch glycolate
Blister pack, (not marketed), 100 tablets
Prescription
Prescription
Novartis Grimsby Limited
Treatment of: inflammatory and degenerative forms of rheumatism - rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non-articular rheumatism; acute attacks of gout; post-traumatic and postoperative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery; painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis; as an adjuvant in severe painful inflammatory infections of the ear, nose, or throat, e.g. pharyngotonsillitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication.
Package - Contents - Shelf Life: Blister pack, PVC/PE/PVDC/Aluminium foil - 100 tablets - 36 months from date of manufacture stored at or below 30°C - Bottle, plastic, - 50 tablets - 36 months from date of manufacture stored at or below 30°C
1979-08-30
__________________________________________________________________________________________________ VOLTAREN Page 1 of 6 VOLTAREN 50MG TABLETS (DICLOFENAC SODIUM) 75MG SR TABLETS (DICLOFENAC SODIUM) 50MG DISPERSIBLE TABLETS (DICLOFENAC FREE ACID) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Voltaren . It does not contain all the available information . It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking it against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT VOLTAREN IS USED FOR Voltaren relieves pain and reduces inflammation (swelling and redness) that may occur in the following: different types of arthritis including rheumatoid arthritis and osteoarthritis other painful conditions where swelling is a problem such as back pain, rheumatism, muscle strains, sprains and tendonitis (eg. tennis elbow) menstrual cramps (period pain) Voltaren belongs to a family of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). These medicines can relieve the symptoms of pain and inflammation but they will not cure your condition. Your doctor may prescribe Voltaren for another purpose. Ask your doctor if you have any questions about why it has been prescribed for you. Voltaren is only available with a doctor's prescription. It is not addictive. BEFORE YOU TAKE VOLTAREN _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE VOLTAREN IF YOU HAVE AN ALLERGY TO: diclofenac (the active ingredient in Voltaren) or any of the other ingredients listed at the end of this leaflet other medicines containing diclofenac (eg. Voltaren Emulgel) aspirin/ acetylsalicylic acid any other NSAID medicine Many medicines used to treat headache, period pain and other aches and pains contain aspirin or NSAID medicines. If you are not sure Citiți documentul complet
NEW ZEALAND DATA SHEET Page 1 of 15 1 PRODUCT NAME VOLTAREN® 50 mg Enteric coated tablet 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 50 mg Tablet: Each enteric coated tablet contains 50 mg of diclofenac sodium. List of excipients with known effect: lactose monohydrate For the full list of excipients, see section 6.1 This product is not able to deliver all approved dose regimens. 3 PHARMACEUTICAL FORM Enteric coated tablets. 50 mg Tablets: Light brown, round, slightly biconvex, enteric coated tablets with bevelled edges. Imprints: ‘GT’ on one side and ‘CG’ on the other side. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Treatment of: Inflammatory and degenerative forms of rheumatism: rheumatoid arthritis, juvenile rheumatoid arthritis, ankylosing spondylitis, osteoarthritis and spondylarthritis, painful syndromes of the vertebral column, non‐articular rheumatism. Acute attacks of gout. Post‐traumatic and post‐operative pain, inflammation, and swelling, e.g. following dental or orthopaedic surgery. Painful and/or inflammatory conditions in gynaecology, e.g. primary dysmenorrhoea or adnexitis. Migraine attacks. As an adjuvant in severe painful inflammatory infections of the ear, nose or throat, e.g. pharyngotonsillitis, otitis. In keeping with general therapeutic principles, the underlying disease should be treated with basic therapy, as appropriate. Fever alone is not an indication. 4.2 DOSE AND METHOD OF ADMINISTRATION This product is not able to deliver all approved dose regimens. Voltaren should only be prescribed when the benefits are considered to outweigh the potential risks. After assessing the risk/benefit ratio in each individual patient, the lowest effective dose for the shortest possible duration should be used. Adverse effects may be minimized by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). Dosage GENERAL POPULATION NEW ZEALAND DATA SHEET Page 2 of 15 The recommended initial daily dose is 100 to 150 Citiți documentul complet